Newly Approved Drugs: How Should Do We Use Them in the Clinic?
308 views · Published 6 December 2015 · 5:20 · Indexed 25 October 2026
Channel: American Society of Hematology · 2015 · Nonprofits & Activism
Idarucizumab, blinatumumab, and panobinostat have been recently approved to treat hematologic diseases, but how should they be used in the clinic? Mikkael Sekeres, MD, MS, discusses their appropriate dosing, potential interactions, and other issues clinicians face in treating patients with these new drugs.
More from this channel
-
1:52
Ron Reagan Accepts ASH Award - Stem Cell Research
-
4:25
Sen. Jim Talent's Work on Sickle Cell Disease Legislation
-
3:56
ASH and the Reagans Support Stem Cell Research
-
5:42
The American Society of Hematology Celebrates its 50th Anniversary
-
5:57
David Nathan Receives 2011 Wallace H. Coulter Award for Lifetime Achievement in Hematology
-
5:17
James George Receives 2012 Wallace H. Coulter Award for Lifetime Achievement in Hematology
-
2:21
Congress: Protect NIH funding
-
2:21
Act Now: Tell Congress to Stop Further Cuts to Research Funding